000
| 01329nam##2200337za#4500 |
---|
001 | 9.534150 |
---|
003 | CaOODSP |
---|
005 | 20200401015543 |
---|
007 | ta |
---|
008 | 150406|2000||||xxc||||| f|0| 0 eng|d |
---|
020 | |a0-660-61377-8 |
---|
040 | |aCaOODSP|beng |
---|
041 | |aeng |
---|
041 | |afre |
---|
043 | |an-cn--- |
---|
086 | 1 |aBT31-4/64-2000 |
---|
110 | 1 |aCanada. |bTreasury Board. |
---|
245 | 10|aPatented Medicine Prices Review Board Canada |
---|
260 | |aOttawa - Ontario : |bTreasury Board of Canada Secretariat |c2000. |
---|
300 | |aEnglish text, 34p. : |bgraphs, tables ; |c28 cm. |
---|
490 | 1 |aPerformance report for the period ending March 31, 2000 |
---|
546 | |aBilingual |
---|
563 | |aSoftcover |
---|
590 | |a01-06|b2001-02-09 |
---|
690 | 07|aBudgets|2gcpds |
---|
690 | 07|aFinancial management|2gcpds |
---|
690 | 07|aProductivity|2gcpds |
---|
776 | 0#|tConseil d'examen du prix des médicaments brevetés Canada, rapport sur le rendement pour la période se terminant le 31 mars 2000 |w(CaOODSP)9.600341 |
---|
776 | 0#|tPatented Medicine Prices Review Board Canada, performance report for the period ending March 31, 2000 |w(CaOODSP)9.569100 |
---|
792 | |tConseil d'examen du prix des médicaments brevetés Canada |w(CaOODSP)9.534151 |
---|
830 | #0|aPerformance report for the period ending March 31, 2000.|w(CaOODSP)9.508978 |
---|